NMNAT3 and Parkinson disease: Based on these earlier findings, it is reasonable to suggest that a likely consequence of the observed reduction in NMNAT3 levels both in PD subject brain and in human cells with ectopic expression of α-syn, may in turn cause a reduction in mitochondrial NAD+ synthesis.